bpc 157 clinical trial human dosing bpc-157 protocol BPC-157 Dosing (Common Protocols) 🔹 Oral / Subcutaneous • 500 mcg daily • Duration: 6 weeks 🔹 Intramuscular / Peritendinous • 1 mg daily • Duration: 6 weeks ⚠️ Note: Not approved BPC-157 Dosage Guide: Protocols &

M.HenryL

Established Research Protocols Bioenergetic Restoration (SS-31 + NAD+): Research focusing on cellular senescence often utilises SS-31 (Elamipretide) to stabilise Cardiolipin in the inner mitochondrial membrane, paired with NAD+ to restore the proton gradient

Hach, M., Engelund, D

Apart from low doses, when opting for protocols with weekly macrodoses of supplementation or booster doses, we must provide a very high intake of B12 to ensure that we cover the absorption of a small but sufficient fraction, even at the expense of the vast majority of the B12 in the supplement not being utilized and being eliminated due to the lower absorption efficiency found with this route, as it is not dependent on the intrinsic factor